The Duke CTSA KL2 program provides training and research opportunities for junior investigators that will equip them to:
- Participate in and ultimately lead transdisciplinary research teams that both transcend traditional scientific silos and embrace diverse stakeholder input
- Facilitate advancement of discoveries to their next translational phase
- Represent a more diverse workforce to meet evolving translational science priorities
- Leverage partnerships locally, regionally, and nationally to enhance the impact of their discoveries
These overall goals will be achieved through both group and individually tailored activities for Duke’s KL2 scholars, and by extensive interactions with Duke’s CTSA cores. We expect our scholars to complete the KL2 program equipped and inspired to become successful, independent investigators, making contributions across the entire spectrum of clinical and translational research.
Each year, we will select up to three Duke CTSA KL2 Scholars. Each scholar will be awarded 75% total protected effort for 3 years, up to $20,000/year for research expenses, and up to $2,500/year for travel to professional meetings.
The KL2 program provides support for three years of consecutive funding for each scholar, consisting of consecutive 12-month appointments. Benefits are contingent upon available funds.
- Strongly Recommended Letter of Intent due: November 1, 2021
- Application deadline: November 29, 2021